表紙
市場調查報告書

老年性黃斑部病變:全球臨床實驗趨勢 (2020年前半期)

Age Related Macular Degeneration Global Clinical Trials Review, H1, 2020

出版商 GlobalData 商品編碼 955969
出版日期 內容資訊 英文
訂單完成後即時交付
價格
老年性黃斑部病變:全球臨床實驗趨勢 (2020年前半期) Age Related Macular Degeneration Global Clinical Trials Review, H1, 2020
出版日期: 2020年06月01日內容資訊: 英文
簡介

本報告提供老年性黃斑部病變 (AMD) 相關臨床實驗最新趨勢相關分析,彙整疾病·治療方法概要,及主要已開發國家 (G7各國)·新興國家 (E7各國) 的臨床實驗狀況,各地區·各期 (不同階段)·各階段的進展,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊,為您概述為以下內容。

目錄

目錄

  • 分析概要
  • 本報告分析範圍
  • 各地區的臨床實驗情形
    • 各國臨床實驗數量和平均實驗人數
      • 亞太地區主要5國的臨床實驗數量
      • 歐洲主要5國的臨床實驗數量
      • 北美主要國家的臨床實驗數量
      • 中東·非洲主要國家的臨床實驗數量
      • 中南美主要5國的臨床實驗數量
  • G7各國臨床實驗數量:眼科疾病臨床實驗上的老年性黃斑部病變的比例
  • G7各國臨床實驗數量:各期 (不同階段)
  • G7各國臨床實驗數量:各進展狀況
  • E7各國臨床實驗數量:眼科疾病臨床實驗上的老年性黃斑部病變的比例
  • E7各國臨床實驗數量:各期 (不同階段)
  • E7各國臨床實驗數量:各進展狀況
  • 各期 (不同階段)的臨床實驗數量
    • 進行中的臨床實驗:各期
  • 各進展狀況臨床實驗數量
  • 臨床實驗目標的達成情形
  • 一定期間所採用的實驗對象
  • 贊助商 (臨床試驗贊助者)類別的臨床實驗數量
  • 有潛力的贊助商
    • 老年性黃斑部病變治療藥臨床實驗上的主要參與企業
  • 有潛力的藥劑
  • 老年性黃斑部病變臨床實驗上的最新趨勢
    • 2020年3月9日:參天製藥和TRACON中止對濕性老年性黃斑部病變的DE-122開發
  • 有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC6256CTIDB

GlobalData's clinical trial report, "Age Related Macular Degeneration Global Clinical Trials Review, H1, 2020" provides an overview of Age Related Macular Degeneration Clinical trials scenario. This report provides top line data relating to the clinical trials on Age Related Macular Degeneration. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Age Related Macular Degeneration Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Age Related Macular Degeneration
  • Mar 09, 2020: Santen and TRACON discontinue development of DE-122 for wet age-related macular degeneration
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source

List of Tables

List of Tables

  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Region, 2020*
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
  • Age Related Macular Degeneration Therapeutics Clinical Trials, North America, Top Countries, 2020*
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020*
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020*
  • Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2020*
  • Age Related Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Age Related Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2020*
  • Age Related Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Age Related Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Phase, 2020*
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Age Related Macular Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

List of Figures

List of Figures

  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
  • Age Related Macular Degeneration Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020*
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020*
  • Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2020*
  • Age Related Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Age Related Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Age Related Macular Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2020*
  • Age Related Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Age Related Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Phase (%), 2020*
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
  • Age Related Macular Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Age Related Macular Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Age Related Macular Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
  • GlobalData Methodology